CONNECT WITH US

Orient Pharma leads Taiwan in international certifications with unique management strategy

, Taipei
0

Orient Pharma (OP), a reinvested subsidiary of the Orient EuroPharma Group (OEP), will be listed on Taiwan's over-the-counter (OTC) market in late August 2025...

The article requires paid subscription. Subscribe Now